Werbung
Werbung

ETON

ETON logo

Eton Pharmaceutcials, Inc. Common Stock

15.47
USD
Gesponsert
-1.04
-6.33%
09. Jan., 15:59 UTC -5
Geschlossen
exchange

Nach-Markt

15.45

-0.03
-0.16%

ETON Ergebnisberichte

Positives Überraschungsverhältnis

ETON übertreffen die 12 der letzten 26Schätzungen.

46%

Nächster Bericht

Datum des nächsten Berichts
16. März 2026
Estimate for Q4 25 (Revenue/ EPS)
$20.99M
/
$0.09
Implizierte Änderung von Q3 25 (Revenue/ EPS)
-6.54%
/
-228.57%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
+80.22%
/
-550.00%

Eton Pharmaceutcials, Inc. Common Stock earnings per share and revenue

On 06. Nov. 2025, ETON reported earnings of -0.07 USD per share (EPS) for Q3 25, missing the estimate of 0.09 USD, resulting in a -176.25% surprise. Revenue reached 22.46 million, compared to an expected 20.88 million, with a 7.54% difference. The market reacted with a -11.70% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analysts forecast an EPS of 0.09 USD, with revenue projected to reach 20.99 million USD, implying an decrease of -228.57% EPS, and decrease of -6.54% in Revenue from the last quarter.
FAQ
For Q3 2025, Eton Pharmaceutcials, Inc. Common Stock reported EPS of -$0.07, missing estimates by -176.25%, and revenue of $22.46M, 7.54% above expectations.
The stock price moved down -11.7%, changed from $19.14 before the earnings release to $16.90 the day after.
The next earning report is scheduled for 16. März 2026.
Based on 5 analysts, Eton Pharmaceutcials, Inc. Common Stock is expected to report EPS of $0.09 and revenue of $20.99M for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung